Dr. Francisco J. Calimano, MD

Dr. Calimano practices at AdventHealth Orlando in Orlando, Florida, part of AdventHealth.

Dr. Calimano's NPI, 1194704965, was assigned on January 11, 2006. Dr. Calimano graduated from Universidad Central del Caribe School of Medicine in 1992. Dr. Calimano holds Florida license ME67831.

Dr. Calimano's primary practice is AdventHealth Orlando, at 601 E Rollins St, Orlando, FL 32803 in Orange County. The practice phone is (407) 303-1976.

Dr. Calimano's primary practice is AdventHealth Orlando in Orlando, Florida, part of AdventHealth. Dr. Calimano is also affiliated with AdventHealth DeLand. The medical group on file is AdventHealth Medical Group. Dmand AI also links Dr. Calimano to 2 more group practices and clinics, 1 physician office and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Calimano practices, 5 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Calimano's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Calimano is board certified in critical care medicine by the American Board of Internal Medicine. Dr. Calimano is licensed in Florida.

Dmand AI lists asthma, bronchitis, chronic lung disease, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, hypersomnia, pleural effusion and pneumonia among the conditions Dr. Calimano treats.

CMS data shows 3,669 Medicare services from Dr. Calimano across 15 procedure codes in 2024, for 951 Medicare patients. Medicare paid $245,480 for them.

CMS counts 951 Medicare patients who saw Dr. Calimano in 2024. The largest group is 75 to 84, with 372 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Calimano's median patient age at 72, with 60% women.

In 2024, Dr. Calimano wrote 4,742 Medicare Part D claims for 736 patients. CMS names the drug for 4,457 of them, across 46 drugs with 11 or more claims each, at $5,879,568 in total drug cost. In 2023, CMS named 4,602 claims across 46 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Calimano for performance year 2024, reported as part of a group. Dr. Calimano accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Calimano as offering telehealth.

CMS Open Payments shows 1,403 general payments to Dr. Calimano from 67 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 76% of the total. GlaxoSmithKline, LLC. paid the most, $128,493.

Dmand AI lists 1 award for Dr. Calimano, most recently CMS Stage 1 2012 in 2012.

Dr. Calimano graduated from Universidad Central del Caribe School of Medicine in 1992.

Dr. Calimano is in network with 18 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.